Your browser doesn't support javascript.
loading
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry.
Hanoun, Maher; Ruhnke, Leo; Kramer, Michael; Hanoun, Christine; Schäfer-Eckart, Kerstin; Steffen, Björn; Sauer, Tim; Krause, Stefan W; Schliemann, Christoph; Mikesch, Jan-Henrik; Kaufmann, Martin; Hänel, Mathias; Jost, Edgar; Brümmendorf, Tim H; Fransecky, Lars; Kraus, Sabrina; Einsele, Hermann; Niemann, Dirk; Neubauer, Andreas; Kullmer, Johannes; Seggewiss-Bernhard, Ruth; Görner, Martin; Held, Gerhard; Kaiser, Ulrich; Scholl, Sebastian; Hochhaus, Andreas; Reinhardt, H Christian; Platzbecker, Uwe; Baldus, Claudia D; Müller-Tidow, Carsten; Bornhäuser, Martin; Serve, Hubert; Röllig, Christoph.
Affiliation
  • Hanoun M; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany. maher.hanoun@uk-essen.de.
  • Ruhnke L; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.
  • Kramer M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.
  • Hanoun C; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
  • Schäfer-Eckart K; Department of Internal Medicine 5, Hospital Nuernberg, Nuernberg, Germany.
  • Steffen B; Department of Hematology and Oncology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
  • Sauer T; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Krause SW; Department of Hematology and Medical Oncology, University Hospital Erlangen, Erlangen, Germany.
  • Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Mikesch JH; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Kaufmann M; Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Hänel M; Department of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany.
  • Jost E; Department of Internal Medicine IV, University Hospital RWTH, Aachen, Germany.
  • Brümmendorf TH; Department of Internal Medicine IV, University Hospital RWTH, Aachen, Germany.
  • Fransecky L; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kraus S; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Niemann D; Department of Internal Medicine, Hematology and Oncology, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany.
  • Neubauer A; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
  • Kullmer J; Department of Internal Medicine II, IAKO Bremen, Bremen, Germany.
  • Seggewiss-Bernhard R; Department of Internal Medicine V, Sozialstiftung Bamberg, Bamberg, Germany.
  • Görner M; Department of Hematology, Oncology and Palliative Medicine, Klinikum Bielefeld Mitte, Bielefeld, Germany.
  • Held G; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Homburg, Germany.
  • Kaiser U; Department of Hematology and Oncology, St. Bernward Hospital, Hildesheim, Germany.
  • Scholl S; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
  • Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
  • Reinhardt HC; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
  • Platzbecker U; Department for Internal Medicine I, University Hospital Leipzig, Leipzig, Germany.
  • Baldus CD; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Müller-Tidow C; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.
  • Serve H; National Center for Tumor Disease Dresden (NCT/UCC), Dresden, Germany.
  • Röllig C; Department of Hematology and Oncology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
J Cancer Res Clin Oncol ; 149(8): 4611-4621, 2023 Jul.
Article in En | MEDLINE | ID: mdl-36167894
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Risk_factors_studies Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Risk_factors_studies Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Type: Article Affiliation country: Germany